2021. EV Targeting MCF-7 Breast Cancer Cell Lines Inhibit Both mTOR and HIF-1A: Molecular Docking Study. Medico Legal Update. 21, 1 (Jan. 2021), 1367–1373. DOI:https://doi.org/10.37506/mlu.v21i1.2511.